Blacks with throat cancer get harsher therapy

Key points
- Blacks in the U.S. with throat cancer are more likely than whites to have surgery that leaves them unable to speak than to get gentler voice-preserving treatments, a new study finds.
- Previous research has found a similar racial disparity in breast cancer treatment, with blacks more often having the entire breast removed instead of just the cancerous lumps.
- Allen Chen, who led the new study, said poverty, less education and deep-rooted historical biases could all be at work.
- "There could be an underlying distrust among African Americans where they feel anything less than surgery might be considered quote-unquote experimental," Chen, a radiation oncologist at University of California, Davis, told Reuters Health.
Blacks in the U.S. with throat cancer are more likely than whites to have surgery that leaves them unable to speak than to get gentler voice-preserving treatments, a new study finds.
Previous research has found a similar racial disparity in breast cancer treatment, with blacks more often having the entire breast removed instead of just the cancerous lumps.
It's unclear why the gap exists. But Dr. Allen Chen, who led the new study, said poverty, less education and deep-rooted historical biases could all be at work.
"There could be an underlying distrust among African Americans where they feel anything less than surgery might be considered quote-unquote experimental," Chen, a radiation oncologist at University of California, Davis, told Reuters Health.
He referenced the Tuskegee experiment, conducted by the U.S. government into the 1970s, in which black patients with syphilis went untreated despite assurances to the contrary.
"That sort distrust needs to be addressed or alleviated," Chen said, because voice-preserving treatment for throat cancer, based on radiation and drug therapy, is now the standard.
Laryngeal cancer is one of the most common head and neck cancers. In 2009, an estimated 12,290 adults (9,920 men and 2,370 women) in the United States will be diagnosed with laryngeal cancer. It is estimated that 3,660 deaths (2,900 men and 760 women) from this disease will occur this year.
Each year, an estimated 2,400 adults (1,900 men and 500 women) in the United States will be diagnosed with hypopharyngeal cancer.Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of cases of this type of cancer in the United States each year, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with laryngeal or hypopharyngeal cancer. Because statistics are measured in five-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer.Statistics adapted from the American Cancer Society’s publication, Cancer Facts & Figures 2009.
His study, published in the Archives of Otolaryngology - Head & Neck Surgery, is based on data from a U.S. cancer registry including nearly 5,400 cases of laryngeal cancer between 1991 and 2008.
About 80 percent of whites had voice-preserving treatment, while the rest had their voice box surgically removed - the traditional approach.
Among blacks, 75 percent had the gentler therapy. While that's only a five-percent difference, "I think it's still a gap that needs to be narrowed," Chen said.
Throat Cancer Throat cancer is any kind of malignant tumor that is found within the confines of the larynx and the hypopharynx. Throat cancer is known to come in two forms laryngeal cancer and hypopharyngeal cancer. Throat cancer afflicts roughly 12,290 new people every year and kills approximately 3,990 people annually. Throat cancer used to be among the top twenty most common cancers in the United States. It is now less common due to the decreasing number of Americans that smoke. Similar trends are shown world wide. Excessive consumption of alcohol also increases the risk of throat cancer. Causes of Throat Cancer There is no known cause of throat cancer; however, major risk factors show an increased incidence of it among "at risk" segments of the population. Risk factors of throat cancer include the use of tobacco, excessive consumption of alcohol, human papilloma virus (which is a sexually transmitted disease), poor oral hygiene, environmental pollutions. The use of tobacco and alcohol together further increases this risk. Types of Throat Cancer There are two types of throat cancer based on the location of the cancer when it was found: laryngeal and hypolaryngeal. The larynx is the part of the throat that contains the vocal chords, in men, this part is commonly known as the Adam's apple. The larynx is part of the respiratory system and protects the vocal chords. Cancers that begin here are called laryngeal cancers. The hypopharynx is the structure located at the beginning of the esophagus. It is part of the digestive system and it prevents food from going into the larynx and trachea. The hypolarynx facilitates the body's swallowing mechanism. Cancers that begin at the hypopharynx are called hypopharyngeal cancers. Throat Cancer Symptoms Throat cancer symptoms include lingering sore throat, trouble or pain swallowing, a constantly recurring cough, sudden unexplained weight loss, a lump or mass in the neck, change in quality of the voice, hoarseness that lasts more than two weeks, or lingering ear pain.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsReview highlights potential of cancer immunotherapy plus targeted therapy
The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests "we are finally poised to deliver curative therapies to cancer patients," researchers at The…
10 April 2015
NewsEven low-androgen triple-negative breast cancer responds to anti-androgen therapy
A University of Colorado Cancer Center study published today in the journal Molecular Cancer Therapeutics shows that only about 1 percent of triple-negative breast cancer cells in a tumor must be…
25 February 2015
NewsNew study reveals how to improve chemotherapy use in prostate cancer
Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease. A study published online this week (January 17th) in…







